Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-(4-(1-((s(r))-s-methylsulfonimidoyl)cyclopropyl)-6-((3r)-3-methyl-4-morpholinyl)-2-pyrimidinyl)-1h-pyrrolo(2,3-b)pyridine
2. Azd-6738
3. Azd6738
1. Azd6738
2. 1352226-88-0
3. Chembl4285417
4. Azd-6738
5. Imino-methyl-[1-[6-[(3r)-3-methylmorpholin-4-yl]-2-(1h-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane
6. Bdbm50468001
7. Bdbm60432
8. Azd 6738
9. Vjm
10. Ceralasertib (usan/inn)
11. Gtpl9390
12. Schembl9979340
13. Ex-a1101
14. Mfcd29472273
15. Nsc780249
16. Nsc800979
17. S7693
18. Akos032960475
19. Zinc143911816
20. Ccg-268794
21. Cs-5187
22. Nsc-780249
23. Nsc-800979
24. (r)-imino(methyl)(1-(6-((r)-3-methylmorpholino)-2-(1h-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl)cyclopropyl)-l6-sulfanone
25. Ac-32647
26. Hy-19323
27. A15794
28. D11787
29. J-690141
30. (2r)-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-[(4-methylphenyl)sulfonyl]-2-piperidinecarboxamide
31. (r)-3-methyl-4-(6-(1-((r)-s-methylsulfonimidoyl)cyclopropyl)-2-(1h-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl)morpholine
32. (r)-imino(methyl)(1-{6-[(3r)-3-methylmorpholin-4-yl]-2-(1h-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl}cyclopropyl)-lambda6-sulfanone
33. 4-{4-[(3r)-3-methylmorpholin-4-yl]-6-[1-((r)-s-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1h-pyrrolo[2,3-b]pyridine
Molecular Weight | 412.5 g/mol |
---|---|
Molecular Formula | C20H24N6O2S |
XLogP3 | 2.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 412.16814520 g/mol |
Monoisotopic Mass | 412.16814520 g/mol |
Topological Polar Surface Area | 116 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 724 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
76
PharmaCompass offers a list of Ceralasertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ceralasertib manufacturer or Ceralasertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ceralasertib manufacturer or Ceralasertib supplier.
PharmaCompass also assists you with knowing the Ceralasertib API Price utilized in the formulation of products. Ceralasertib API Price is not always fixed or binding as the Ceralasertib Price is obtained through a variety of data sources. The Ceralasertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ceralasertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceralasertib, including repackagers and relabelers. The FDA regulates Ceralasertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceralasertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ceralasertib supplier is an individual or a company that provides Ceralasertib active pharmaceutical ingredient (API) or Ceralasertib finished formulations upon request. The Ceralasertib suppliers may include Ceralasertib API manufacturers, exporters, distributors and traders.
Ceralasertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ceralasertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ceralasertib GMP manufacturer or Ceralasertib GMP API supplier for your needs.
A Ceralasertib CoA (Certificate of Analysis) is a formal document that attests to Ceralasertib's compliance with Ceralasertib specifications and serves as a tool for batch-level quality control.
Ceralasertib CoA mostly includes findings from lab analyses of a specific batch. For each Ceralasertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ceralasertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceralasertib EP), Ceralasertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceralasertib USP).